These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25186529)

  • 1. Are personality traits associated with white-coat and masked hypertension?
    Terracciano A; Scuteri A; Strait J; Sutin AR; Meirelles O; Marongiu M; Orru M; Pilia MG; Ferrucci L; Cucca F; Schlessinger D; Lakatta E
    J Hypertens; 2014 Oct; 32(10):1987-92; discussion 1992. PubMed ID: 25186529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proportion of US Adults Recommended Out-of-Clinic Blood Pressure Monitoring According to the 2017 Hypertension Clinical Practice Guidelines.
    Booth JN; Hubbard D; Sakhuja S; Yano Y; Whelton PK; Wright JT; Shimbo D; Muntner P
    Hypertension; 2019 Aug; 74(2):399-406. PubMed ID: 31230550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.
    Stergiou GS; Asayama K; Thijs L; Kollias A; Niiranen TJ; Hozawa A; Boggia J; Johansson JK; Ohkubo T; Tsuji I; Jula AM; Imai Y; Staessen JA;
    Hypertension; 2014 Apr; 63(4):675-82. PubMed ID: 24420553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinic and ambulatory blood pressure in a population-based sample of African Americans: the Jackson Heart Study.
    Thomas SJ; Booth JN; Bromfield SG; Seals SR; Spruill TM; Ogedegbe G; Kidambi S; Shimbo D; Calhoun D; Muntner P
    J Am Soc Hypertens; 2017 Apr; 11(4):204-212.e5. PubMed ID: 28285829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of white-coat and masked hypertension in national and international registries.
    Gorostidi M; Vinyoles E; Banegas JR; de la Sierra A
    Hypertens Res; 2015 Jan; 38(1):1-7. PubMed ID: 25319601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of patients with white-coat and masked hypertension.
    Mancia G; Bombelli M; Seravalle G; Grassi G
    Nat Rev Cardiol; 2011 Aug; 8(12):686-93. PubMed ID: 21826071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender specific profiles of white coat and masked hypertension impacts on arterial structure and function in the SardiNIA study.
    Scuteri A; Morrell CH; Orru' M; AlGhatrif M; Saba PS; Terracciano A; Ferreli LA; Loi F; Marongiu M; Pilia MG; Delitala A; Tarasov KV; Schlessinger D; Ganau A; Cucca F; Lakatta EG
    Int J Cardiol; 2016 Aug; 217():92-8. PubMed ID: 27179214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of the Home-Clinic Blood Pressure Difference: A Systematic Review and Meta-Analysis.
    Sheppard JP; Fletcher B; Gill P; Martin U; Roberts N; McManus RJ
    Am J Hypertens; 2016 May; 29(5):614-25. PubMed ID: 26399981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white-coat and masked hypertension in the population.
    Asayama K; Thijs L; Li Y; Gu YM; Hara A; Liu YP; Zhang Z; Wei FF; Lujambio I; Mena LJ; Boggia J; Hansen TW; Björklund-Bodegård K; Nomura K; Ohkubo T; Jeppesen J; Torp-Pedersen C; Dolan E; Stolarz-Skrzypek K; Malyutina S; Casiglia E; Nikitin Y; Lind L; Luzardo L; Kawecka-Jaszcz K; Sandoya E; Filipovský J; Maestre GE; Wang J; Imai Y; Franklin SS; O'Brien E; Staessen JA;
    Hypertension; 2014 Nov; 64(5):935-42. PubMed ID: 25135185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood Pressure Measurement and Treatment Decisions.
    Kario K; Thijs L; Staessen JA
    Circ Res; 2019 Mar; 124(7):990-1008. PubMed ID: 30920932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of ambulatory blood pressure phenotypes using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds: data from the Coronary Artery Risk Development in Young Adults study.
    Poudel B; Booth JN; Sakhuja S; Moran AE; Schwartz JE; Lloyd-Jones DM; Lewis CE; Shikany JM; Shimbo D; Muntner P
    J Hypertens; 2019 Jul; 37(7):1401-1410. PubMed ID: 31145711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients.
    Pierdomenico SD; Pierdomenico AM; Coccina F; Porreca E
    Am J Hypertens; 2017 Nov; 30(11):1106-1111. PubMed ID: 29059303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of masked and white-coat hypertension: the family-based SKIPOGH study.
    Alwan H; Pruijm M; Ponte B; Ackermann D; Guessous I; Ehret G; Staessen JA; Asayama K; Vuistiner P; Younes SE; Paccaud F; Wuerzner G; Pechere-Bertschi A; Mohaupt M; Vogt B; Martin PY; Burnier M; Bochud M
    PLoS One; 2014; 9(3):e92522. PubMed ID: 24663506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain.
    Gijón-Conde T; Graciani A; López-García E; Guallar-Castillón P; García-Esquinas E; Rodríguez-Artalejo F; Banegas JR
    Hypertens Res; 2017 Jun; 40(6):613-619. PubMed ID: 28179625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical outcomes of white-coat and masked hypertension: Analysis of a large ambulatory blood pressure database.
    Tocci G; Presta V; Figliuzzi I; Attalla El Halabieh N; Battistoni A; Coluccia R; D'Agostino M; Ferrucci A; Volpe M
    J Clin Hypertens (Greenwich); 2018 Feb; 20(2):297-305. PubMed ID: 29370477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.
    Fukuhara M; Arima H; Ninomiya T; Hata J; Hirakawa Y; Doi Y; Yonemoto K; Mukai N; Nagata M; Ikeda F; Matsumura K; Kitazono T; Kiyohara Y
    Stroke; 2013 Jun; 44(6):1512-7. PubMed ID: 23640825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population.
    Cuspidi C; Facchetti R; Bombelli M; Sala C; Tadic M; Grassi G; Mancia G
    J Hypertens; 2018 Sep; 36(9):1833-1839. PubMed ID: 29965885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term and Long-Term Reproducibility of Hypertension Phenotypes Obtained by Office and Ambulatory Blood Pressure Measurements.
    de la Sierra A; Vinyoles E; Banegas JR; Parati G; de la Cruz JJ; Gorostidi M; Segura J; Ruilope LM
    J Clin Hypertens (Greenwich); 2016 Sep; 18(9):927-33. PubMed ID: 26890293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of changing home blood pressure monitoring cutoff from 135/85 to 130/80 mmHg on hypertension phenotypes.
    Feitosa ADM; Mota-Gomes MA; Barroso WS; Miranda RD; Barbosa ECD; Brandão AA; Nobre F; Mion D; Amodeo C; Lima-Filho JL; Sposito AC; Nadruz W
    J Clin Hypertens (Greenwich); 2021 Jul; 23(7):1447-1451. PubMed ID: 33955645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between ambulatory versus clinic blood pressure according to global cardiovascular risk group.
    Shin J; Park SH; Kim JH; Ihm SH; Kim KI; Kim WS; Pyun WB; Kim YM; Choi SI; Kim SK
    Korean J Intern Med; 2015 Sep; 30(5):610-9. PubMed ID: 26354055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.